Eleven Biotherapeutics (EBIO) Reports Q1 Loss of $0.33/Share

Eleven Biotherapeutics (NASDAQ: EBIO) reported Q1 EPS of ($0.33), versus ($0.36) reported last year. Revenue for the quarter came in at $277 thousand, versus $114 thousand reported last year.

For earnings history and earnings-related data on Eleven Biotherapeutics (EBIO) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
• Medtronic jumps on earnings beat and raised guidance